OBJECTIVE: Preterm birth is the leading cause of perinatal morbidity and mortality. Vaginal progesterone and Arabin cervical pessary are both considered as preventive treatments in women at risk for preterm birth. However, there is little evidence as to which of these two interventions is the preferred management. The objective was to compare the rate of preterm delivery in pregnant women with a short cervical length managed with Arabin cervical pessary and vaginal progesterone versus vaginal progesterone alone STUDY DESIGN: This was a retrospective cohort study of singletons pregnancies managed in two tertiary medical centers between September 2011 and May 2017. One center utilized the combined treatment of Arabin cervical pessary and vaginal progesterone (study group) and the second utilized vaginal progesterone approach (control group). RESULTS: During the study period, a total of 202 pregnant women who underwent vaginal ultrasonography between 15-29 weeks gestation. They all had short cervical length ( 25 mm). Among them 94 (46.5%) and 108 (53.5%) patients were in the study and control group respectively. A significantly higher rate of patients in the study group had either a history of cervical incompetence (9.6% vs 0.9% respectively, P¼0.006) or cervical surgery (7.9% vs 0% respectively, P¼0.003). Despite having shorter cervical length at recruitment (14.3AE5.9 vs 16.9AE5.7 respectively, P¼0.002) the rate of spontaneous delivery<34 weeks gestation was lower in the study group (7.4% vs 17.6% respectively, P¼0.036) and they delivered one week later compared to the control group (37.2AE2.1 vs 36.2AE3.7 respectively, P¼0.02). CONCLUSION: We found that for pregnant women with singletons and who had a short cervical length, the combined treatment of Arabin cervical pessary and vaginal progesterone had lower rate of preterm delivery<34 weeks of gestation and prolonged gestation compared to those women who were treated with vaginal progesterone alone.
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338 How to define intrauterine-growth-restriction e based on sonographic growth curves or neonatal birthweight growth curves? OBJECTIVE: Intra-Uterine-Growth-Restriction (IUGR) is suspected when estimated fetal weight (EFW) <10 th percentile. Using a sonographic EFW growth curve (S-EFW) to diagnose IUGR has no known benefits. We aimed to assess the outcomes of pregnancies complicated with IUGR based on S-EFW in comparison to Appropriate for Gestational Age (AGA) and IUGR based solely on neonatal birthweight (BW) growth curves (N-BW) growth curves.
STUDY DESIGN: Retrospective study; computerized records in a single large university medical center. We included all women with singleton pregnancy and a sonographic EFW between 24-36 weeks who delivered at our center, 2010-2016. Each pregnancy was assigned to one of three groups based on the earliest EFW performed: G1-AGA, G2-IUGR based on S-EFW but not N-BW growth curves or G3-IUGR based solely on N-BW (figure).
Primary outcome was rate of BW<10 th percentile (SGA, small for gestational age). Secondary outcomes included rates of stillbirth, cesarean delivery, preterm delivery, NICU admission, Apgar<7 at 5 minutes and major congenital anomalies. Univariate analyses included Chi-square, one way ANOVA and Kruskal-Wallis tests. Multivariable logistic model controlling for confounders was used to assess the independent role of groups on primary outcome. All tests are two-sided. P value<0.05 was considered statistically significant. Analyses were carried out using SPSS software package version22 (IBM, Armonk, NY). RESULTS: 6005 women met inclusion criteria. Of those 5386 pregnancies (89.6%) were categorized as G1, 300 (5%) as G2 and 319 (5.3%) as G3. Maternal and pregnancies characteristics and outcomes are detailed in table. Primary outcome -rates of BW<10 th percentile was statistically different between groups G1 9.2%, G2 39.7% and G3 70%. Multivariable logistic model revealed that, G2 and G3 were independently associated with higher rates of SGA, as referred to G1: ORs 6.47 [4.99-8.40] and 23.99[18.27-31.51] respectively. Secondary outcomes were also statistically different between groups and are detailed in table, e.g. stillbirth rates were G1 0.7%, G2 3% and G3 6.9%. CONCLUSION: Pregnancies complicated with IUGR using N-BW are associated with high rate of SGA and poor outcomes. Similarly, pregnancies complicated with IUGR using S-EFW have higher rates of SGA and higher rates of poor obstetrical outcomes. Consequently, pregnancies complicated by IUGR based on S-EFW solely should be regarded as IUGR.
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